It's a bit misleading to frame stock comp as "60% of revenue" since their expenses are way larger than their revenue. R&D was $6.7B which would be 156% of revenue by the same math.

A better way to look at it is they had about $12.1B in expenses. Stock was $2.5B, or roughly 21% of total costs.